electroCore, Inc. ECOR

Company Overview

electroCore, Inc. is a commercial-stage bioelectronic medicine and wellness company focused on non-invasive vagus nerve stimulation (nVNS) technologies. The company develops handheld neuromodulation devices intended to treat neurological, pain-related, and respiratory conditions through proprietary electrical stimulation of the vagus nerve. electroCore operates primarily within the medical device, digital therapeutics, and bioelectronic medicine industries, with revenue generated through prescription therapies, wellness products, and government-related contracts. Its flagship technology platform is marketed under brands including gammaCore, Truvaga, and related nVNS systems.

The company’s primary markets include headache and migraine treatment, cluster headache management, wellness applications, and select respiratory or military-related use cases. electroCore has positioned itself as a non-invasive alternative to pharmaceutical and implanted-device therapies, emphasizing portability, lower procedural risk, and drug-free treatment approaches. Founded in 2005 and headquartered in New Jersey, the company evolved from an early-stage neuromodulation developer into a publicly traded medical technology company following regulatory clearances and commercialization efforts in the United States and international markets.